Female pattern androgenic alopecia. Androgenic alopecia
Conditions
Interventions
Intervention 1: Intervention group A: half a milligram of oral minoxidil daily for 6 months. Intervention 2: Intervention group B: two and a half milligrams of oral minoxidil daily for 6 months. Inter
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients with clinical diagnosis of female pattern hair loss Sinclair scale one to four Age range 18 to 50 years old Conscious consent to enter the study and the possibility of attending visits and follow-up sessions
Exclusion criteria
Exclusion criteria: Patients taking medication other than vitamins or minerals for alopecia Pregnancy or breastfeeding Patients with serious internal disease, especially heart disease or comorbidities at the treatment site Psychiatric patients Abnormal tests at baseline
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement rate. Timepoint: 3 and 6 months after starting treatment. Method of measurement: By sinclair scale, clinical and dermatoscopic images (Determine the number and thickness of hair shafts per square centimeter). | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety. Timepoint: 3 and 6 months after starting treatment. Method of measurement: Asking the patient about the side effects of treatment.;Tolerability. Timepoint: 3 and 6 months after starting treatment. Method of measurement: With Investigator Assessment of Tolerability scale (zero, low, medium and high or sufficient).;Patient satisfaction. Timepoint: 3 and 6 months after starting treatment. Method of measurement: With Caregiver treatment satisfaction (CTS) questionnaire (completely satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied and completely dissatisfied). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoumeh Roohaninasab
Iran University of Medical Sciences
Outcome results
None listed